Current UV Index
UV index: 0.0
Alice Springs
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
Gold Coast
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0

Click the indexes to view the minimum recommended protection

When the UV index is low, sun protection is generally not needed unless outside for extended periods

UV observations courtesy of ARPANSA

Fast facts

  • Around 36 Australians are diagnosed with Melanoma every day.
  • Australia has one of the highest rates of Melanoma in the world.
  • Approx one person dies every 5 hours from Melanoma in Australia.
  • An estimated 545 Australian women will die from melanoma THIS YEAR.
  • Tanning beds emit dangerous UV rays, increasing the risk of Melanoma.
  • Severe sunburn during childhood can DOUBLE your risk of Melanoma.
  • Melanoma is one of the most preventable forms of cancer.
  • An estimated 1230 Australian men will die from melanoma THIS YEAR.
  • Melanoma is the cancer most likely to affect 15-39 year olds.
  • Melanoma can arise in normal looking skin, a mole or freckle.
  • Melanoma, if detected/treated early, has a survival rate of nearly 100%.
  • There is no cure for melanoma that has spread throughout the body.


Our Focus

The AMRF is currently committed to funding research that meets the following criteria:

* investigating potential treatments for advanced melanoma that are:

* related to the human immune system (immunotherapy)

* low cost

* low toxicity

* for all patients

Current Sponsored Research Projects

1) Analysis of the recently completed EMOTIV Melanoma Vaccine Study.

2)  Immune Cycle Mathematical Analysis - a collaboration between faculties of the University of Adelaide that is delving into proposed cyclical behaviours of the human immune system.

3) Long Term Survival Analysis - ongoing surveillance/analysis of the survivors of the 2000-2010 VMCL trial.

4) Timing Effect of IL-2 Therapy of Melanoma in a Mouse Model (completed - awaiting publication)

5) Timing Effect of Higher Dose IL-2 Therapy of Melanoma in a Mouse Model (completed - undergoing statistical analysis)

Adelaide Melanoma March 2019 in conjunction with Melanoma Institute Australia.

All net proceeds raised through this year’s Melanoma March will support a national collaborative research project that will allow researchers and clinicians to personalise immunotherapies for patients – in essence, to match the treatment provided to the patient with the tumour of that patient.  It will be known as the Personalised Immunotherapy Project and this will be a great stride towards our mission of zero deaths from melanoma.